More on YCBD
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.36 |
|
|||
| Open | $0.37 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.37 | ||||
| Day Low | $0.34 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 65,954 | ||||
- Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation
- cbdMD agrees to acquire Twinlab brands in court-pending deal
- cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness
- Maxim Group Downgrades cbdMD Inc. (YCBD) to Hold
- cbdMD, Inc. (YCBD) Misses Q2 EPS by 7c
- cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026
- cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results
- Senate bill would delay hemp restrictions, cbdMD says portfolio protected
- cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products
- cbdMD backs bipartisan hemp regulation bill ahead of November deadline
Entities mentioned with YCBD
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Dividend | View Related Stories »
- ThinkEquity | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
